BSPM [Biostar Pharmaceuticals,] SC 13D/A: SCHEDULE 13D/A (Amendment No 1) Biostar Pharmaceuticals, (Name

[SCHEDULE 13D/A (Amendment No 1) Biostar Pharmaceuticals, (Name of Issuer)mmon Stock (Title of Class of Securities) 090678103 (CUSIP Number) Rebecca Baum 730 FIFTH AVENUE, 25TH FLOOR NEW YORK, NY 10019 212-359-0204 (Name,dress and Telephone Number of Person Authorized to Receive Notices andmmunications) November 18, 2009 (Date of Event which Requires Filing of this Statement) If]

By | 2016-02-07T17:53:34+00:00 November 30th, 2009|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

GSOL [GLOBAL SOURCES] 6-K: (Original Filing)

[YEAR 2009 / 3 rd QUARTER The following discussion of our financial condition and results of operations should be read in conjunction with the accompanying financial statements. Overview We are a leading business-to-business (B2B) media company and a primary facilitator of two-way trade with Greater China. The core business is facilitating trade from Greater China to the world, using a] [GLOBAL SOURCES LTD. AND SUBSIDIARIES At At September 30, December 31, 2009 2008 (Unaudited) ASSETS Current Assets: Cash and cash equivalents $ 88,821 $ 70,225 Term deposits with banks 60,088 — Available-for-sale securities 6,337 60,786 Accounts receivable, net 3,870 6,025 Receivables from sales representatives 8,076 5,574 Inventory 650 1,306 Prepaid expenses and other current assets]

By | 2016-03-07T20:32:28+00:00 November 30th, 2009|Categories: Chinese Stocks, GSOL, SEC Original|Tags: , , , , , |0 Comments

GSOL [GLOBAL SOURCES] 6-K: YEAR 2009 / 3 rd QUARTER The following

[YEAR 2009 / 3 rd QUARTER The following discussion of our financial condition and results of operations should be read in conjunction with the accompanying financial statements. Overview We are a leading business-to-business (B2B) media company and a primary facilitator of two-way trade with Greater China. The core business is facilitating trade from Greater China to the world, using a] [GLOBAL SOURCES LTD. AND SUBSIDIARIES At At September 30, December 31, 2009 2008 (Unaudited) ASSETS Current Assets: Cash and cash equivalents $ 88,821 $ 70,225 Term deposits with banks 60,088 — Available-for-sale securities 6,337 60,786 Accounts receivable, net 3,870 6,025 Receivables from sales representatives 8,076 5,574 Inventory 650 1,306 Prepaid expenses and other current assets]

By | 2016-03-07T20:33:33+00:00 November 30th, 2009|Categories: Chinese Stocks, GSOL, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar